199 related articles for article (PubMed ID: 20674567)
1. Gatifloxacin-induced histamine release and hyperglycemia in rats.
Ishiwata Y; Yasuhara M
Eur J Pharmacol; 2010 Oct; 645(1-3):192-7. PubMed ID: 20674567
[TBL] [Abstract][Full Text] [Related]
2. Effect of levofloxacin on serum glucose concentration in rats.
Ishiwata Y; Itoga Y; Yasuhara M
Eur J Pharmacol; 2006 Dec; 551(1-3):168-74. PubMed ID: 17026994
[TBL] [Abstract][Full Text] [Related]
3. Effects of gatifloxacin on serum glucose concentration in normal and diabetic rats.
Ishiwata Y; Sanada Y; Yasuhara M
Biol Pharm Bull; 2006 Mar; 29(3):527-31. PubMed ID: 16508159
[TBL] [Abstract][Full Text] [Related]
4. Severe hyperglycemia during renally adjusted gatifloxacin therapy.
Blommel AL; Lutes RA
Ann Pharmacother; 2005; 39(7-8):1349-52. PubMed ID: 15941822
[TBL] [Abstract][Full Text] [Related]
5. Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patients.
Lodise T; Graves J; Miller C; Mohr JF; Lomaestro B; Smith RP
Pharmacotherapy; 2007 Nov; 27(11):1498-505. PubMed ID: 17963459
[TBL] [Abstract][Full Text] [Related]
6. Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature.
Yip C; Lee AJ
Clin Ther; 2006 Nov; 28(11):1857-66. PubMed ID: 17213006
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for hyperglycemia in hospitalized adults receiving gatifloxacin: a retrospective, nested case-controlled analysis.
Mohr JF; Peymann PJ; Troxell E; Lodise TP; Ostrosky-Zeichner L
Clin Ther; 2008 Jan; 30(1):152-7. PubMed ID: 18343251
[TBL] [Abstract][Full Text] [Related]
8. A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
Mohr JF; McKinnon PS; Peymann PJ; Kenton I; Septimus E; Okhuysen PC
Pharmacotherapy; 2005 Oct; 25(10):1303-9. PubMed ID: 16185173
[TBL] [Abstract][Full Text] [Related]
9. Effects of moxifloxacin on serum glucose concentrations in rats.
Ishiwata Y; Takahashi Y; Nagata M; Yasuhara M
Biol Pharm Bull; 2013; 36(4):686-90. PubMed ID: 23358329
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological aspect of dysglycemia in naive and diabetic rats induced by the fluoroquinolone antibacterial gatifloxacin.
Nagai M; Nagata S; Yamagishi N; Satoh H; Furuhama K
J Vet Med Sci; 2010 May; 72(5):567-73. PubMed ID: 20068268
[TBL] [Abstract][Full Text] [Related]
11. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
12. Mechanism Underlying Induction of Hyperglycemia in Rats by Single Administration of Olanzapine.
Nagata M; Nakajima M; Ishiwata Y; Takahashi Y; Takahashi H; Negishi K; Yasuhara M
Biol Pharm Bull; 2016; 39(5):754-61. PubMed ID: 27150145
[TBL] [Abstract][Full Text] [Related]
13. Gatifloxacin induced abnormalities in glucose homeostasis in a patient on glimepiride.
Kesavadev J; Rasheed SA
J Assoc Physicians India; 2006 Dec; 54():951-2. PubMed ID: 17334014
[TBL] [Abstract][Full Text] [Related]
14. Gatifloxacin-induced dysglycemia.
Zvonar R
Am J Health Syst Pharm; 2006 Nov; 63(21):2087-92. PubMed ID: 17057046
[TBL] [Abstract][Full Text] [Related]
15. Advancing age and renal impairment as important predisposing factors of gatifloxacin-induced hyperglycemia in non-diabetes patients.
Ovartlarnporn M; Jongjaroenprasert W
J Med Assoc Thai; 2007 Mar; 90(3):569-73. PubMed ID: 17427537
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting.
LaPlante KL; Mersfelder TL; Ward KE; Quilliam BJ
Pharmacotherapy; 2008 Jan; 28(1):82-9. PubMed ID: 18154478
[TBL] [Abstract][Full Text] [Related]
17. Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats.
Yu Y; Wang X; Liu C; Yao D; Hu M; Li J; Hu N; Liu L; Liu X
Toxicol Appl Pharmacol; 2013 Feb; 266(3):375-84. PubMed ID: 23200776
[TBL] [Abstract][Full Text] [Related]
18. Possible gatifloxacin-induced hyperglycemia.
Donaldson AR; Vandiver JR; Finch CK
Ann Pharmacother; 2004 Apr; 38(4):602-5. PubMed ID: 14982977
[TBL] [Abstract][Full Text] [Related]
19. Hyperglycemia and gatifloxacin: a case report and summary of current literature.
Beste LA; Mersfelder TL
Am J Geriatr Pharmacother; 2005 Dec; 3(4):262-5. PubMed ID: 16503322
[TBL] [Abstract][Full Text] [Related]
20. Plasma glucose-lowering action of Hon-Chi in streptozotocin-induced diabetic rats.
Chang JC; Wu MC; Liu IM; Cheng JT
Horm Metab Res; 2006 Feb; 38(2):76-81. PubMed ID: 16523406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
